We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
As of July 1 2022, OСT Clinical, one of the leading CROs in Eastern Europe, has officially entered theranks of the European CRO Federation (EUCROF).
Founded in 2005, EUCROF has become one of the leading unions for performing high-quality contract research services in Europe in general and in the European Union in particular. The founders have developed a structure focused on effective partnerships and effective communication between members to disseminate innovative approaches among participants, while representing the interests of theindustry as a whole. Another objective of the Federation is to create a reliable legal entity to represent the interests of CROs in the EU, for example, in collaboration with regulatory authorities, the pharmaceutical and biotech industries, the clinical research community, and patient associations.
In June 2022, the Head of OCT Clinical’s Baltic Countries’Division,Gatis Klaucans,represented the company at the biannual General Assembly in Prague. Federation members find it important to participate in assemblies and other events organized by EUCROF. Direct participation and live communication with the participants help to establish cooperation and partnerships.
“We are honored to become a part of the European CRO Federation along with other respected member organizations. We are highly motivated to do our part in contributing to the development of the clinical research ecosystem across European countries and are excited about the opportunities for collaboration with fellow colleagues while carrying outbest practices together,” said Mr. Klaucans.
“It was a great pleasure to meet friends and colleagues in person. We are happy to welcome OCT Clinical to our Federation, and look forward to achieving new heights together,” said Dr Martine Dehlinger-Kremer, President of EUCROF.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
